//]]>

Neurofibromatosis Type 1 (Record no. 18191)

000 -LEADER
fixed length control field 03612nam a22004935i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150244.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130129s2012 gw | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783642328640
978-3-642-32864-0
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RB155-155.8
Classification number QH431
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 611.01816
Edition number 23
Classification number 599.935
Edition number 23
264 #1 -
-- Berlin, Heidelberg :
-- Springer Berlin Heidelberg :
-- Imprint: Springer,
-- 2012.
912 ## -
-- ZDB-2-SBL
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Upadhyaya, Meena.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Neurofibromatosis Type 1
Medium [electronic resource] :
Remainder of title Molecular and Cellular Biology /
Statement of responsibility, etc edited by Meena Upadhyaya, David N. Cooper.
300 ## - PHYSICAL DESCRIPTION
Extent XVI, 717 p. 75 illus., 60 illus. in color.
Other physical details online resource.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note From the Contents: von Recklinghausen disease -- Clinical diagnosis and atypical cases -- Management and treatment of NF1: complex UK NF1 clinics -- Mortality in NF1 -- The cognitive profile of NF1 children, therapeutic implications -- Clinical expression of NF1 in monozygotic twins -- Whole body MRI studies in NF1 patients -- Quality of Life in NF1 -- NF1 gene: promoter, 3’UTR and complex features -- Germline mutational spectrum of  NF1 and Genotype-Phenotype Correlations -- Splicing mechanisms and mutations in the NF1 gene -- NF1 Germline and somatic mosaicism -- Deep intronic NF1 mutations and possible therapeutic interventions -- NF1 microdeletions and mutational mechanisms -- NF1 somatic mutational spectrum -- Social Stigma in NF1 -- Personalized Medicine in NF1 -- Future Directions - Where do we go from here.
520 ## - SUMMARY, ETC.
Summary, etc Neurofibromatosis type 1 (NF1), caused by mutational inactivation of the NF1 tumour suppressor gene, is one of the most common dominantly inherited human disorders, affecting 1 in 3000 individuals worldwide. This book presents in concise fashion, but as comprehensively as possible, our current state of knowledge on the molecular genetics, molecular biology and cellular biology of this tumour predisposition syndrome. Written by internationally recognized experts in the field, the 44 chapters that constitute this edited volume provide the reader with a broad overview of the clinical features of the disease, the structure and expression of the NF1 gene, its germ line and somatic mutational spectra and genotype-phenotype relationships, the structure and function of its protein product (neurofibromin), NF1 modifying loci, the molecular pathology of NF1-associated tumours, animal models of the disease, psycho-social aspects and future prospects for therapeutic treatment. Neurofibromatosis Type 1: Molecular and Cellular Biology will be of great value to medical geneticists, molecular and cellular biologists, oncologists, dermatologists, neurologists, genetic counsellors and general practitioners alike.  
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Human genetics.
Topical term or geographic name as entry element Neurosciences.
Topical term or geographic name as entry element Biomedicine.
Topical term or geographic name as entry element Human Genetics.
Topical term or geographic name as entry element Cancer Research.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Molecular Medicine.
Topical term or geographic name as entry element Neurosciences.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cooper, David N.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9783642328633
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-3-642-32864-0
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-07AUM Main Library2014-04-07 2014-04-07 E-Book   AUM Main Library611.01816

Languages: 
English |
العربية